XML 19 R8.htm IDEA: XBRL DOCUMENT v3.22.4
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 3 Months Ended 12 Months Ended 13 Months Ended
Nov. 30, 2022
Nov. 30, 2021
Aug. 31, 2022
Nov. 30, 2022
Operating activities:        
Net income $ 13,997 $ 18,555    
Adjustments to reconcile net income to net cash provided by operating activities:        
Depreciation and amortization 1,896 1,987    
Net gains on sales and disposals of property and equipment 122 9    
Deferred income taxes 271 738    
Stock-based compensation 2,719 2,891    
Unrealized foreign currency exchange losses (gains) (1,481) 541    
Provision for credit losses 30 30    
Changes in assets and liabilities:        
Trade and other accounts receivable 2,847 (7,980)    
Inventories (14,203) (13,054)    
Other assets 4,573 (1,793)    
Operating lease assets and liabilities, net 26 2    
Accounts payable and accrued liabilities (3,336) 4,126    
Accrued payroll and related expenses 2,627 (7,324)    
Other long-term liabilities and income taxes payable 349 325    
Net cash provided by (used in) operating activities 10,437 (947)    
Investing activities:        
Purchases of property and equipment (1,458) (2,434)    
Proceeds from sales of property and equipment 158 72    
Net cash used in investing activities (1,300) (2,362)    
Financing activities:        
Treasury stock purchases (4,072) (7,386)   $ (33,200)
Dividends paid (10,634) (9,905)    
Repayments of long-term senior notes (400) (400)    
Net proceeds from revolving credit facility 3,364      
Shares withheld to cover taxes upon conversions of equity awards (600) (4,246)    
Net cash used in financing activities (12,342) (21,937)    
Effect of exchange rate changes on cash and cash equivalents 2,244 (1,196)    
Net decrease in cash and cash equivalents (961) (26,442)    
Cash and cash equivalents at beginning of period 37,843 85,961 $ 85,961  
Cash and cash equivalents at end of period 36,882 59,519 $ 37,843 $ 36,882
Supplemental disclosure of noncash investing activities:        
Accrued capital expenditures $ 315 $ 294